Home
 > News
print small

Participating Countries:

Algeria

Argentina

Australia

Austria

Belgium

Bosnia and Herzegovina

Bulgaria

Croatia

Czech Republic

Denmark

Finland

France

FYR of Macedonia

Germany

Greece

Iceland

Ireland

Israel

Italy

Lithuania

Morocco

Netherlands

New Zealand

Poland

Portugal

Romania

Russian Federation

Serbia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States

Member area provided by LTFE
COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST

An article on success of irreversible electroporation in clinics (PR Newswire)

27/04/2015


Tell your friend  | 

A new item entitled "New Data Shows Irreversible Electroporation Nearly Doubles Overall Survival of Patients with Locally Advanced Pancreatic Cancer When Added to Standard Therapy" appeared April 24th on PR Newswire, reporting on the recently published results from the Soft Tissue Ablation Registry (STAR), demonstrating exciting clinical prospects for irreversible electroporation.

Read more at the original source: link.


Project Office

Working groups

Steering Committee

Founding members

DC Rapporteurs

Related sites: